3one4 Capital — 2021 Investments
5 investments dated 2021 · listed companies and verified rows first · show all
Breathe Well-being offers a mobile-based weight loss and lifestyle management program delivered through remote coaching, a mobile app with tracking and educational content, and peer support communities.
HealthtechWellness & FitnessNew Delhi, IN
Aditya Kaicker(Founder)inRohan Verma(Founder)in
Co-investorsAccelPowerhouse VenturesY CombinatorGeneral Catalyst
.png)
Fasal builds smart irrigation and agriculture automation products, including the FasalJet irrigation controllers, FasalJet Pro fertigation automation system, and soil moisture/temperature sensors and weather stations.
AgTechHardwareIoT
Ananda Verma(Founder)inShailendra Tiwari(Founder)in
Co-investorsBeyond Capital VenturesMount Parker VenturesThe Yield Lab Asia PacificBritish International InvestmentOmnivoreTDK Ventures+2 more
.jpeg){kind=logo}
HexaHealth is an India-based "phygital" healthcare platform that guides patients through their treatment journey, using an AI-powered recommendation engine to match them with doctors and accredited hospitals and to handle admissions, insurance, financing, and post-treatment recovery.
AI & Machine LearningDigital HealthHealthtech
Co-investorsChiratae VenturesOmidyar Network
Hypto is a financial infrastructure platform offering developer-friendly Open Banking APIs for collections and payouts, supporting fund transfers via IMPS, NEFT, RTGS, and UPI, virtual accounts, and UPI ID/QR issuance.
Data & InfrastructureDeveloper ToolsFintech
Co-investorsStellaris Venture Advisors 2 Llp
Koo.bz develops manufacturing technology for footwear production, combining expertise in apparel design and additive manufacturing to build a scalable footwear factory in the United States.
Advanced ManufacturingCreator EconomyDeep TechE-commerceHardwareVentura, US
Co-investorsPathbreaker VenturesAccelBlume VenturesKalaari CapitalTiger Global Management
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.